Skip to main content
. 2016 Aug 29;11:1169–1174. doi: 10.2147/CIA.S107881

Table 1.

Comparison of clinicopathological and treatment characteristics of patients with differentiated thyroid carcinoma aged below 60 years and above 60 years at presentation

Variables Aged below 60 years (n=252) Aged above 60 years (n=118) P-value
Age (years)
 Median (range) SD 51.9 (46–60) ±4.2 68.6 (62–97) ±565.2 0.022
Sex, n (%)
 M 50 (19.8) 28 (12.3)
 F 202 (74.1) 90 (87.7) 0.235
Tumor size (cm)
 Median (range) SD 2.92 (0.3–11) ±1.97 2.88 (0.2–10) ±1.87 0.653
Histology, n (%)
 Papillary 235 (93.3) 109 (92.4) 0.063
 Classic 149 (63.4) 46 (42.2) 0.003
 Follicular 63 (26.8) 44 (40.2) 0.002
 Tall cell 18 (7.6) 13 (11.9) 0.041
 Sclerosing 5 (2.2) 6 (5.5) 0.044
 Follicular 17 (6.7) 9 (7.6) 0.065
T stage, n (%)
 T1 70 (27.8) 28 (23.7)
 T2 106 (42.1) 36 (30.5) 0.018
 T3 62 (24.5) 47 (39.9)
 T4 14 (5.6) 7 (5.9)
N stage, n (%)
 N0 184 (73.1) 67 (56.9)
 N1 68 (26.9) 51 (43.2) 0.002
 N1a 30 (44.2) 30 (58.8)
 N1b 38 (55.8) 21 (41.2)
M stage, n (%)
 M0 242 (96.0) 105 (88.9) 0.010
 M1 10 (4.0) 13 (11.0)
Multifocality, n (%)
 Yes 76 (30.2) 52 (44.1) 0.006
 No 176 (69.8) 66 (55.9)
LVSI, n (%)
 Yes 63 (25.0) 48 (40.7) 0.003
 No 189 (75.0) 70 (59.3)
Surgery, n (%)
 Total thyroidectomy 215 (85.3) 99 (83.9)
 Near total thyroidectomy 37 (14.7) 19 (16.1) 0.065
Neck dissection, n (%)
 No 46 (18.2) 38 (32.2)
 Yes 206 (81.7) 80 (67.8) 0.027
 Central 104 (50.5) 48 (60.0)
 Lateral 102 (49.5) 32 (40.0)
Adjuvant RAI therapy, n (%)
 No 35 (13.9) 9 (6.9)
 Yes 217 (84.9) 109 (89.8) 0.460
 30 mCi 41 (18.9) 15 (13.7)
 100 mCi 48 (22.1) 21 (19.3)
 150 mCi 117 (53.9) 58 (53.3)
 200 mCi 11 (5.1) 15 (13.7)

Note: Data in bold indicates statistical significance.

Abbreviations: n, number; DTC, differentiated thyroid cancer; SD, standard deviation; M, male; F, female; T, tumor; N, node; M, metastasis; LVSI, lymphovascular space invasion; RAI, radioactive iodine; mCi, millicurie.